Appointments
All Deals
Declared | Dealt | Type | EPIC | Company | Director | Pos | Shares | Price | Value | Cur. price | % Gain | Gain |
---|---|---|---|---|---|---|---|---|---|---|---|---|
20/01/21 | 18/01/21 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 846 | $19.08 | $16,142 | 1,446.40p | 0.00 | |
20/01/21 | 18/01/21 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 1,078 | $19.08 | $20,568 | 1,446.40p | 0.00 | |
11/01/21 | 07/01/21 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 2,170 | $19.04 | $41,306 | 1,446.40p | 0.00 | |
11/01/21 | 07/01/21 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 388 | $19.04 | $7,386 | 1,446.40p | 0.00 | |
23/12/20 | 21/12/20 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 2,301 | $18.11 | $41,671 | 1,446.40p | 0.00 | |
09/12/20 | 07/12/20 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 2,218 | $18.78 | $41,654 | 1,446.40p | 0.00 | |
25/11/20 | 23/11/20 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 2,269 | $18.37 | $41,682 | 1,446.40p | 0.00 | |
17/11/20 | 12/11/20 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 3,872 | $18.88 | $73,084 | 1,446.40p | 0.00 | |
17/11/20 | 12/11/20 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 86 | $18.88 | $1,623 | 1,446.40p | 0.00 | |
11/11/20 | 09/11/20 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 2,223 | $18.75 | $41,670 | 1,446.40p | 0.00 | |
02/11/20 | 29/10/20 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 6,748 | $16.98 | $114,581 | 1,446.40p | 0.00 | |
02/11/20 | 29/10/20 | BUY | GSK | Glaxosmithkline PLC | Hal Barron | ED | 296,993 | $16.98 | $5,042,941 | 1,446.40p | 0.00 | |
14/10/20 | 12/10/20 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 818 | $18.58 | $15,198 | 1,446.40p | 0.00 | |
14/10/20 | 12/10/20 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 1,042 | $18.58 | $19,360 | 1,446.40p | 0.00 | |
15/01/20 | 13/01/20 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 812 | $23.33 | $18,940 | 1,446.40p | 0.00 | |
15/10/19 | 14/10/19 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 826 | $21.13 | $17,449 | 1,446.40p | 0.00 | |
15/07/19 | 12/07/19 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 856 | $20.47 | $17,518 | 1,446.40p | 0.00 | |
16/04/19 | 12/04/19 | DRIP | GSK | Glaxosmithkline PLC | Hal Barron | ED | 1,076 | $20.47 | $22,026 | 1,446.40p | 0.00 | |
15/02/19 | 13/02/19 | TIN | GSK | Glaxosmithkline PLC | Hal Barron | ED | 37,120 | £0.00 | £0 | 1,446.40p | 0.00 |
Showing 1 to 19 of 19
Transaction types:
- BUY - Buy
- SELL - Sell
- EXR - Exercise
- SEXR - Sale Post-Exercise
- DRI - Dividend Reinvestment
- DRIP - Dividend Reinvestment Plan
- AWD - Award
- TIN - Transfer In
- TOUT - Transfer Out
- LOF - In Lieu of Fees/Salary
- SI - Scrip Issue
- PLAC - Placing
- RIS - Rights Issue
Director positions:
- CEO - Chief Executive Officer
- CH - Chairman
- MD - Managing Director
- FD - Financial Director
- NED - Non Executive Director
- ED - Executive Director
- RES - Resigned
- D - Director / Unknown